A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

NCT00462748 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

786

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ezetimibe (+) simvastatin
DRUG: Comparator: atorvastatin
DRUG: Comparator: rosuvastatin

Sponsor

Organon and Co